More seriously, patients in the high-risk group had a lower immune activity, including lower immune cell infiltration such as T cell CD4+, T cell CD8+, and downregulation of HLA family genes and immune checkpoints expression such as HLA-A, HLA-B, PD1, and CTLA4, which contributed to immunosuppression and tumor immune escape. This evidence concerns the gene HLA-B and neoplasm.